Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Share News (GWP)

  • There is currently no data for GWP

GWP.L News

GW Pharmaceuticals Prices USD148 Million ADS Offering In New York
19 Jun 2014

GW Pharmaceuticals Prices USD148 Million ADS Offering In New York

LONDON (Alliance News) - GW Pharmaceuticals PLC Thursday priced its offering of 1.7 million American depositary shares on the NASDAQ exchange in New Y...

UK MORNING BRIEFING: Rolls-Royce Leads Strong Opening Gains
19 Jun 2014

UK MORNING BRIEFING: Rolls-Royce Leads Strong Opening Gains

LONDON (Alliance News) - UK shares have opened strongly higher Thursday, and the pound has broken above USD1.70, following a well-received US Federal ...

UK MIDDAY BRIEFING: BOE Policy Makers Still Unanimous
18 Jun 2014

UK MIDDAY BRIEFING: BOE Policy Makers Still Unanimous

LONDON (Alliance News) - Bank of England policymakers unanimously decided to leave the key interest rates and asset purchase programme unchanged at th...

UK WINNERS & LOSERS: Iraq Crisis Lifts Oil Prices, Oil Companies
18 Jun 2014

UK WINNERS & LOSERS: Iraq Crisis Lifts Oil Prices, Oil Companies

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.-------FTSE 100 - WIN...

BUZZ-GW Pharmaceuticals Plc: Public offering of ADRs
18 Jun 2014

BUZZ-GW Pharmaceuticals Plc: Public offering of ADRs

** The drugmaker's American depositary shares down 7.11 percent at $83.43 premarket. ** The UK-based company said it planned to sell 1.7 million of i...

GW Pharmaceuticals To Sell 1.7 Million American Depositary Shares
18 Jun 2014

GW Pharmaceuticals To Sell 1.7 Million American Depositary Shares

LONDON (Alliance News) - GW Pharmaceuticals PLC Wednesday announced plans to sell 1.7 million American depositary shares representing GW ordinary shar...

GW Pharmaceuticals receives encouraging data from epilepsy drug trial
18 Jun 2014

GW Pharmaceuticals receives encouraging data from epilepsy drug trial

GW Pharmaceuticals on Wednesday reported encouraging results from a 12-week trial of its Cannabis-based Epidiolex drug on patients with severe types o...